A new study of some 5,000 older people in the UK has shown that rates of long-term cognitive decline are steeper in those who have diabetes compared with people with normal blood sugar control, and that efforts to delay the ...
Jan 25, 2018
0
11
(HealthDay)—About 1 in every 160 pregnancies in the United States ends in stillbirth. Now, a new study suggests many of these tragedies are "potentially" avoidable.
Jan 19, 2018
0
4
A cost analysis by researchers at the University of Chicago Medicine shows treatment plans that set individualized blood sugar goals for diabetes patients, tailored to their age and health history, can save $13,546 in health ...
Dec 11, 2017
0
21
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.
Oct 17, 2017
0
7
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...
Sep 14, 2017
0
26
Six meals per day is better than three for blood sugar control in obese people with impaired glucose tolerance (prediabetes) or full-blown type 2 diabetes, suggests new research presented at this year's European Association ...
Sep 13, 2017
0
1
The Centers for Disease Control and Prevention reports 84 million Americans have prediabetes. Unless something is done, 70 percent will eventually be diagnosed with type 2 diabetes.
Aug 7, 2017
0
2
Heart disease is a leading cause of death worldwide and exacerbated by type 2 diabetes, yet diabetes treatment regimens tend to focus primarily on blood sugar maintenance. This common approach to type 2 diabetes management ...
Jun 20, 2017
2
440
In a landmark study, UNC School of Medicine researchers have shown that blood glucose testing does not offer a significant advantage in blood sugar control or quality of life for type 2 diabetes patients who are not treated ...
Jun 10, 2017
0
65
Benjamin U. Nwosu, MD, has developed a valuable new tool in the battle against type 1 diabetes, according to a study published May 1 by PLOS ONE.
May 3, 2017
0
23
